ERIN SHUMARD: Open Payments
NPI 1184134843 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 16 payments from 9 companies in 2025. Trend: 2023 $257 · 2024 $218 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 1 | $104 |
| PFIZER INC. | 4 | $78 |
| ABBVIE INC. | 4 | $69 |
| Lilly USA, LLC | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Yescarta, QULIPTA, TRUMENBA, MOUNJARO, KOSELUGO, PREVNAR 20, VRAYLAR, Rybelsus.
Industry payments across ID — which companies pay providers there.
